Dr. Rosenberg is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4501 X St
Ste 3016
Sacramento, CA 95817Phone+1 916-734-5981Fax+1 916-734-0631
Education & Training
Tufts Medical CenterFellowship, Hematology and Medical Oncology, 2010 - 2013
Temple University HospitalResidency, Internal Medicine, 2007 - 2009- Temple University HospitalInternship, Internal Medicine, 2006 - 2007
Icahn School of Medicine at Mount SinaiClass of 2006
Wesleyan UniversityBA, 1997 - 2001
Certifications & Licensure
CA State Medical License 2014 - 2026
MA State Medical License 2010 - 2015
PA State Medical License 2006 - 2010
Clinical Trials
- Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma Start of enrollment: 2013 Dec 06
- Ixazomib With Pomalidomide, Clarithromycin and Dexamethasone in Treating Patients With Multiple Myeloma Start of enrollment: 2015 Oct 01
- AMG 176 First in Human Trial in Participants With Relapsed or Refractory Multiple Myeloma and Participants With Relapsed or Refractory Acute Myeloid Leukemia Start of enrollment: 2016 Jun 13
- Join now to see all
Publications & Presentations
PubMed
- 124 citationsCarfilzomib or bortezomib in combination with lenalidomide and dexamethasone for patients with newly diagnosed multiple myeloma without intention for immediate autolog...Shaji Kumar, Susanna Jacobus, Adam D. Cohen, Matthias Weiss, Natalie S. Callander
The Lancet. Oncology. 2020-10-01 - 43 citationsDecreased early mortality associated with the treatment of acute myeloid leukemia at National Cancer Institute‐designated cancer centers in CaliforniaGwendolyn Ho, Theodore Wun, Lori Muffly, Qian Li, Ann Brunson
Cancer. 2018-05-01 - 16 citationsMultiple Myeloma, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology.Shaji K Kumar, Natalie S Callander, Kehinde Adekola, Larry D Anderson Jr, Muhamed Baljevic
Journal of the National Comprehensive Cancer Network. 2023-12-01
Journal Articles
- Association Between Autologous Stem Cell Transplant and Survival Among Californians with Multiple MyelomaAaron S Rosenberg, Brian A Jonas, Journal of the National Cancer Institute
Abstracts/Posters
- Blinatumomab/Lenalidomide in Relapsed/Refractory Non-HodgkinÍs Lymphoma: A Phase I California Cancer Consortium Study of Safety, Efficacy and Immune Correlative AnalysisAaron Seth Rosenberg, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Phase I Study of Escalating Doses of Carfilzomib with Hyper-CVAD in Patients with Newly Diagnosed Acute Lymphoblastic Leukemia/LymphomaAaron Seth Rosenberg, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
